Dr. Padmanabhan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1720 Nicholasville Rd
Ste 701
Lexington, KY 40503Phone+1 859-276-0414Fax+1 859-276-3765
Education & Training
- University of Kentucky College of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011
- University of South Florida MorsaniResidency, Internal Medicine, 2005 - 2007
- University of Kentucky College of MedicineInternship, Internal Medicine, 2004 - 2005
- University of Kentucky College of MedicineClass of 2004
Certifications & Licensure
- KY State Medical License 2008 - 2025
- FL State Medical License 2007 - 2009
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013-2014
Clinical Trials
- S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Start of enrollment: 2013 May 15
Publications & Presentations
PubMed
- 32 citationsRRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancerDaniel Morgensztern, Michal G. Rose, Saiama N. Waqar, John C. Morris, Patrick C. Ma
British Journal of Cancer. 2019-07-30 - 15 citationsReal-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.Scott A. Tomlins, Daniel H. Hovelson, Jennifer Marie Suga, Daniel M. Anderson, Han A. Koh
JCO Precision Oncology. 2021-08-19 - 8 citationsMulticenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.Craig L. Slingluff, Karl D. Lewis, Robert H.I. Andtbacka, John R. Hyngstrom, Mohammed M. Milhem
Journal for Immunotherapy of Cancer. 2021-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: